News release: First clinical study patient has novel drug delivery system implanted for Parkinson’s trial (docx)

File size: 106 kB Language: English

News release: First clinical study patient has novel drug delivery system implanted for Parkinson’s trial

On November 8th, 2017 the first patient in a new clinical study was implanted with a novel drug delivery system, developed by Renishaw, The procedure took place at Karolinska University Hospital in Stockholm, Sweden. The implantation marks the beginning of a joint clinical study between Renishaw and Herantis Pharma. This phase I - II clinical study will investigate the treatment of Parkinson’s disease using Cerebral Dopamine Neurotrophic Factor (CDNF) delivered with Renishaw’s system.

This type of file requires a viewer, freely available from Microsoft

Latest videos - Neurological products

Latest items - Neurological products

Email me when this file is updated

Didn't find what you were looking for?

Tell us what you couldn’t find and we will do our best to help